BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3352656)

  • 21. The PCr/Pi ratio in in vivo injured rat brain.
    Pogliani L; Ishige N
    In Vivo; 1990; 4(3):191-3. PubMed ID: 2133262
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human leg neuromuscular diseases: P-31 MR spectroscopy.
    Bárány M; Siegel IM; Venkatasubramanian PN; Mok E; Wilbur AC
    Radiology; 1989 Aug; 172(2):503-8. PubMed ID: 2748832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial regulation of phosphocreatine/inorganic phosphate ratios in exercising human muscle: a gated 31P NMR study.
    Chance B; Eleff S; Leigh JS; Sokolow D; Sapega A
    Proc Natl Acad Sci U S A; 1981 Nov; 78(11):6714-8. PubMed ID: 6947247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metabolic myopathy in canine muscle-type phosphofructokinase deficiency.
    Giger U; Argov Z; Schnall M; Bank WJ; Chance B
    Muscle Nerve; 1988 Dec; 11(12):1260-5. PubMed ID: 2976895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further impairment of muscle phosphate kinetics by lengthening exercise in DMD/BMD carriers. An in vivo 31P-NMR spectroscopy study.
    Barbiroli B; McCully KK; Iotti S; Lodi R; Zaniol P; Chance B
    J Neurol Sci; 1993 Oct; 119(1):65-73. PubMed ID: 8246012
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscle injury and exercise stress measured with 31-P magnetic resonance spectroscopy.
    McCully KK; Kent JA; Chance B
    Prog Clin Biol Res; 1989; 315():197-207. PubMed ID: 2798487
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic consequences of repeated exercise in long distance runners.
    Yoshida T; Watari H
    Eur J Appl Physiol Occup Physiol; 1993; 67(3):261-5. PubMed ID: 8223541
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Two-dimensional proton magnetic resonance of human muscle extracts.
    Venkatasubramanian PN; Arús C; Bárány M
    Clin Physiol Biochem; 1986; 4(5):285-92. PubMed ID: 3022979
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased incidence of a resonance in the phosphodiester region of 31P nuclear magnetic resonance spectra in the skeletal muscle of fibromyalgia patients.
    Jubrias SA; Bennett RM; Klug GA
    Arthritis Rheum; 1994 Jun; 37(6):801-7. PubMed ID: 8003051
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exertional muscle injury: evaluation of concentric versus eccentric actions with serial MR imaging.
    Shellock FG; Fukunaga T; Mink JH; Edgerton VR
    Radiology; 1991 Jun; 179(3):659-64. PubMed ID: 2027970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Altered muscle metabolism shown by magnetic resonance spectroscopy in sickle cell disease with leg ulcers.
    Norris SL; Gober JR; Haywood LJ; Halls J; Boswell W; Colletti P; Terk M
    Magn Reson Imaging; 1993; 11(1):119-23. PubMed ID: 8423714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reduced oxidative muscle metabolism in chronic fatigue syndrome.
    McCully KK; Natelson BH; Iotti S; Sisto S; Leigh JS
    Muscle Nerve; 1996 May; 19(5):621-5. PubMed ID: 8618560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simultaneous acquisition of phosphocreatine and inorganic phosphate images for Pi:PCr ratio mapping using a RARE sequence with chemically selective interleaving.
    Greenman RL; Wang X; Smithline HA
    Magn Reson Imaging; 2011 Oct; 29(8):1138-44. PubMed ID: 21641744
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muscle ischaemia in peripheral vascular disease studied by 31P-magnetic resonance spectroscopy.
    Hands LJ; Sharif MH; Payne GS; Morris PJ; Radda GK
    Eur J Vasc Surg; 1990 Dec; 4(6):637-42. PubMed ID: 2279575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Proceedings: Living muscle studied by 31P nuclear magnetic resonance.
    Dawson J; Gadian DG; Wilkie DR
    J Physiol; 1976 Jun; 258(2):82P-83P. PubMed ID: 957191
    [No Abstract]   [Full Text] [Related]  

  • 36. Metabolic changes in human muscle denervation: topical 31P NMR spectroscopy studies.
    Zochodne DW; Thompson RT; Driedger AA; Strong MJ; Gravelle D; Bolton CF
    Magn Reson Med; 1988 Aug; 7(4):373-83. PubMed ID: 3173055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton magnetic resonance spectroscopic studies of hypertrophied muscle. Effect of botulinum toxin treatment.
    Narayana PA; Slopis JM; Jackson EF; Jankovic J; Butler IJ
    Invest Radiol; 1991 Jan; 26(1):58-64. PubMed ID: 2022454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A morphological study of delayed muscle soreness.
    Fridén J; Sjöström M; Ekblom B
    Experientia; 1981 May; 37(5):506-7. PubMed ID: 7250326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of muscle damage on
    Lopez C; Batra A; Moslemi Z; Rennick A; Guice K; Zeng H; Walter GA; Forbes SC
    NMR Biomed; 2022 Mar; 35(3):e4659. PubMed ID: 34841594
    [No Abstract]   [Full Text] [Related]  

  • 40. Musculoskeletal MR Imaging Applications at Ultra-High (7T) Field Strength.
    Menon RG; Chang G; Regatte RR
    Magn Reson Imaging Clin N Am; 2021 Feb; 29(1):117-127. PubMed ID: 33237012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.